Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

heart patient

Heart specialists push for change due to rising number of CVD deaths

"It’s clear to me that urgent intervention is long overdue," one cardiologist said in a statement. 

January 22, 2024
Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

Top 15 heart-healthy diets: Experts call Mediterranean, DASH the best of the best

U.S. News has shared its annual ranking of the best diets for a person's heart. Weight Watchers, Jenny Craig and Noom are out in 2024, replaced by three different options that prioritize plant-based foods. 

January 4, 2024
Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow

HeartFlow’s AI-powered CAD offering reaches a significant milestone

The company's trademark offering has now been used to evaluate one quarter of a million patients. 

January 3, 2024
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.

New drugs, updated treatment strategies: 5 important trends in cardiology from an eventful 2023

Revisit some of the year's biggest trends in the diagnosis, treatment and prevention of cardiovascular disease. 

December 20, 2023
Newsweek ranked the 50 best heart hospitals in the world

Hybrid coronary revascularization vs. CABG for multivessel CAD: New meta-analysis tracks long-term outcomes

A hybrid approach may increase the risk of certain adverse events, according to a new meta-analysis focused on long-term outcomes. 

December 18, 2023
business launch

‘A true breakthrough’: The eye-opening potential of GLP-1 agonists to treat heart, kidney disease in addition to obesity

While GLP-1 drugs were originally developed to treat diabetes, researchers keep finding additional ways these medications can potentially benefit patients.

December 15, 2023
Newsweek ranked the 50 best heart hospitals in the world

Deaths from CVD are on the rise, cardiologists warn—high blood pressure, obesity remain 2 primary culprits

Cardiovascular disease remains one of the leading causes of mortality in the world, responsible for nearly 20 million deaths in 2022 alone. 

December 11, 2023
Pills

ADHD medications associated with heightened CVD risk

"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained. 

November 22, 2023

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup